S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
pixel
Log in
NASDAQ:MOTS

Motus GI Stock Forecast, Price & News

$1.13
+0.05 (+4.63 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.10
Now: $1.13
$1.25
50-Day Range
$0.82
MA: $1.01
$1.19
52-Week Range
$0.46
Now: $1.13
$2.37
Volume7.40 million shs
Average Volume611,231 shs
Market Capitalization$36.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.79
Motus GI Holdings, Inc., a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.
Motus GI logo

MarketRank

Overall MarketRank

1.68 out of 5 stars

Medical Sector

192nd out of 1,556 stocks

Surgical & Medical Instruments Industry

26th out of 137 stocks

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MOTS
CUSIPN/A
Phone954-541-8000
Employees49

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$110,000.00
Book Value$0.64 per share

Profitability

Net Income$-23,090,000.00
Net Margins-12,916.77%

Miscellaneous

Market Cap$36.43 million
Next Earnings Date3/29/2021 (Estimated)
OptionableNot Optionable
$1.13
+0.05 (+4.63 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MOTS News and Ratings via Email

Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Motus GI (NASDAQ:MOTS) Frequently Asked Questions

How has Motus GI's stock price been impacted by COVID-19?

Motus GI's stock was trading at $1.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MOTS shares have increased by 8.7% and is now trading at $1.13.
View which stocks have been most impacted by COVID-19
.

Is Motus GI a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Motus GI stock.
View analyst ratings for Motus GI
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Motus GI?

Wall Street analysts have given Motus GI a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Motus GI wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Motus GI's next earnings date?

Motus GI is scheduled to release its next quarterly earnings announcement on Monday, March 29th 2021.
View our earnings forecast for Motus GI
.

How were Motus GI's earnings last quarter?

Motus GI Holdings, Inc. (NASDAQ:MOTS) issued its quarterly earnings results on Thursday, November, 12th. The company reported ($0.13) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.13). The firm had revenue of $0.03 million for the quarter, compared to the consensus estimate of $0.03 million. Motus GI had a negative net margin of 12,916.77% and a negative return on equity of 151.69%.
View Motus GI's earnings history
.

What price target have analysts set for MOTS?

5 equities research analysts have issued 1 year price objectives for Motus GI's stock. Their forecasts range from $2.00 to $2.60. On average, they anticipate Motus GI's stock price to reach $2.40 in the next twelve months. This suggests a possible upside of 112.4% from the stock's current price.
View analysts' price targets for Motus GI
or view Wall Street analyst' top-rated stocks.

Who are some of Motus GI's key competitors?

What other stocks do shareholders of Motus GI own?

Who are Motus GI's key executives?

Motus GI's management team includes the following people:
  • Mr. Timothy P. Moran, CEO & Director (Age 49, Pay $1.54M)
  • Mr. Mark Pomeranz, Pres, COO & Director (Age 59, Pay $554.27k)
  • Mr. Andrew Lawrence Taylor M.B.A., Chief Financial Officer (Age 50, Pay $423.37k)
  • Mr. Scott C. Aldrich Jr., VP of Marketing & Strategy

When did Motus GI IPO?

(MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at a price of $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager.

What is Motus GI's stock symbol?

Motus GI trades on the NASDAQ under the ticker symbol "MOTS."

How do I buy shares of Motus GI?

Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Motus GI's stock price today?

One share of MOTS stock can currently be purchased for approximately $1.13.

How big of a company is Motus GI?

Motus GI has a market capitalization of $36.43 million and generates $110,000.00 in revenue each year. The company earns $-23,090,000.00 in net income (profit) each year or ($0.92) on an earnings per share basis. Motus GI employs 49 workers across the globe.

What is Motus GI's official website?

The official website for Motus GI is www.motusgi.com.

How can I contact Motus GI?

Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 954-541-8000 or via email at [email protected]

This page was last updated on 1/17/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.